Tekla Capital Management LLC Vectiv Bio Holding Ag Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$7.34 - $9.15 $402,745 - $502,060
-54,870 Reduced 7.44%
682,834 $5.81 Million
Q4 2022

Feb 10, 2023
SELL
$7.79 - $8.98 $146,436 - $168,806
-18,798 Reduced 2.48%
737,704 $6.39 Million
Q3 2021

Nov 12, 2021
BUY
$6.7 - $11.54 $4.1 Million - $7.06 Million
611,502 Added 421.73%
756,502 $5.37 Million
Q2 2021

Aug 13, 2021
BUY
$11.66 - $24.23 $1.69 Million - $3.51 Million
145,000 New
145,000 $1.69 Million

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0
View Full List

About VectivBio Holding AG

VECT Quotes by TradingView
  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email